HSL Mobile App Reports
Gain valuable insights from our periodic reports on stocks with analysis and comments from our research team after quarterly and yearly corporate result announcements.
The global defence sector has entered a structurally elevated growth phase, driven by persistent geopolitical conflicts, rapid technologi...
We maintain BUY on JK Cement (JKCE), with an unchanged target price of INR 6,495/share (15x FY28E consolidated EBITDA). As per our recent...
We recently interacted with IPCA management, while visiting their Unichem Goa plant (Formulation units I and II) and R&D facility (ce...
Tata Elxsi's growth is expected to recover to low double digits in FY27E, anchored by engineering engagements that are more core and stic...
We maintain our BUY rating on Dalmia Bharat with an unchanged target price of INR 2,470/share (12x its FY28E consolidated EBITDA). As per...
AI disruption unfolds differently across industries, yet Mphasis maintains a strong near- to medium-term outlook, supported by a solid de...
The aggregate performance of the Q3FY26 earnings season was robust as YoY PAT growth steadily improved to reach low double-digit level bu...
Lending financials (Mixed) (Revenue/PAT growth (YoY): 8%/10% and (QoQ): 4%/5%) Large banks reported strong performance led by healthy dou...
ABB India Ltd (ABB) reported a stable quarter with revenue/EBITDA/APAT beat/(miss) of +4.0/5%/in line respectively. ABB’s Q4CY25 orde...
Alkem MedTech (a w.o.s of Alkem Labs) to acquire 51-55% stake in Occlutech Holding AG (Occlutech) for cash consideration of Euro 99.4 mn,...
Subscribe for our
newsletter
newsletter
